Jane Street Group, LLC Uro Gen Pharma Ltd. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

A detailed history of Jane Street Group, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 22,417 shares of URGN stock, worth $355,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,417
Previous 16,609 34.97%
Holding current value
$355,981
Previous $249,000 34.94%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.81 - $19.33 $80,208 - $112,268
5,808 Added 34.97%
22,417 $336,000
Q4 2023

Feb 14, 2024
BUY
$10.87 - $15.93 $71,220 - $104,373
6,552 Added 65.15%
16,609 $249,000
Q3 2023

Nov 14, 2023
SELL
$8.84 - $22.64 $29,154 - $74,666
-3,298 Reduced 24.69%
10,057 $140,000
Q2 2023

Aug 14, 2023
SELL
$8.75 - $14.29 $625,756 - $1.02 Million
-71,515 Reduced 84.26%
13,355 $138,000
Q1 2023

May 15, 2023
BUY
$7.99 - $11.02 $678,111 - $935,267
84,870 New
84,870 $784,000
Q4 2020

Feb 17, 2021
SELL
$17.54 - $25.43 $381,284 - $552,797
-21,738 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$18.81 - $26.42 $9,931 - $13,949
-528 Reduced 2.37%
21,738 $419,000
Q2 2020

Aug 17, 2020
BUY
$16.5 - $29.7 $128,650 - $231,570
7,797 Added 53.89%
22,266 $582,000
Q1 2020

May 15, 2020
SELL
$13.68 - $34.6 $235,980 - $596,850
-17,250 Reduced 54.38%
14,469 $258,000
Q4 2019

Feb 14, 2020
BUY
$21.11 - $34.86 $669,588 - $1.11 Million
31,719 New
31,719 $1.06 Million
Q3 2018

Nov 14, 2018
SELL
$41.65 - $51.7 $190,048 - $235,907
-4,563 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$48.35 - $65.33 $220,621 - $298,100
4,563 New
4,563 $227,000

Others Institutions Holding URGN

# of Institutions
113
Shares Held
24M
Call Options Held
46.9K
Put Options Held
44.3K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $361M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email